Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
BMC Health Serv Res ; 20(1): 341, 2020 Apr 21.
Artigo em Inglês | MEDLINE | ID: mdl-32316963

RESUMO

BACKGROUND: The End TB Strategy calls for global scale-up of preventive treatment for latent tuberculosis infection (LTBI), but little information is available about the associated human resource requirements. Our study aimed to quantify the healthcare worker (HCW) time needed to perform the tasks associated with each step along the LTBI cascade of care for household contacts of TB patients. METHODS: We conducted a time and motion (TAM) study between January 2018 and March 2019, in which consenting HCWs were observed throughout a typical workday. The precise time spent was recorded in pre-specified categories of work activities for each step along the cascade. A linear mixed model was fit to estimate the time at each step. RESULTS: A total of 173 HCWs in Benin, Canada, Ghana, Indonesia, and Vietnam participated. The greatest amount of time was spent for the medical evaluation (median: 11 min; IQR: 6-16), while the least time was spent on reading a tuberculin skin test (TST) (median: 4 min; IQR: 2-9). The greatest variability was seen in the time spent for each medical evaluation, while TST placement and reading showed the least variability. The total time required to complete all steps along the LTBI cascade, from identification of household contacts (HHC) through to treatment initiation ranged from 1.8 h per index TB patient in Vietnam to 5.2 h in Ghana. CONCLUSIONS: Our findings suggest that the time requirements are very modest to perform each step in the latent TB cascade of care, but to achieve full identification and management of all household contacts will require additional human resources in many settings.


Assuntos
Administração de Caso , Pessoal de Saúde , Recursos em Saúde , Tuberculose Latente , Adulto , Benin , Canadá , Feminino , Gana , Humanos , Indonésia , Tuberculose Latente/diagnóstico , Tuberculose Latente/terapia , Modelos Lineares , Masculino , Pessoa de Meia-Idade , Estudos de Tempo e Movimento , Vietnã
2.
Int J Tuberc Lung Dis ; 4(4): 340-4, 2000 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10777083

RESUMO

SETTING: The Komfo Anokye Teaching Hospital, Kumasi, Ghana, West Africa. OBJECTIVE: To evaluate simple and commonly used parameters of the acute-phase response as correlates of successful resolution of smear-positive pulmonary tuberculosis (PTB) during drug treatment. DESIGN: Serum C-reactive protein (CRP) concentration, erythrocyte sedimentation rate (ESR), body weight, and blood haemoglobin were measured in human immunodeficiency virus (HIV) negative Ghanaian patients with PTB (n = 15) and in age- and sex-matched healthy controls (n = 15). These parameters were subsequently measured in patients after 1, 2 and 3 months of antituberculosis treatment. Serum concentrations of soluble interleukin-2-receptor-alpha (sCD25) were also measured as a comparative index of resolution of the systemic inflammatory process. RESULTS: Anti-tuberculosis treatment resulted in sputum smear conversion in all 15 patients. After one month of treatment, reductions in serum CRP concentration (>20%) and increases in haemoglobin concentration (>0.4 g/dl) occurred in the majority of patients and correlated with steep reductions in serum levels of sCD25. In contrast, weight loss and elevated ESR were slower to resolve, and were insensitive early markers of response to treatment. CONCLUSION: A fall in serum CRP and a rise in blood haemoglobin are correlates of the initial response to drug treatment of PTB. These parameters may assist in the evaluation of empiric trials of treatment in microbiologically unconfirmed cases of suspected PTB.


Assuntos
Reação de Fase Aguda/etiologia , Reação de Fase Aguda/imunologia , Antituberculosos/uso terapêutico , Sedimentação Sanguínea , Peso Corporal , Proteína C-Reativa/efeitos dos fármacos , Proteína C-Reativa/metabolismo , Hemoglobinas/análise , Receptores de Interleucina-2/sangue , Tuberculose Pulmonar/tratamento farmacológico , Tuberculose Pulmonar/imunologia , Reação de Fase Aguda/sangue , Adulto , Biomarcadores/sangue , Estudos de Casos e Controles , Monitoramento de Medicamentos , Feminino , Gana , Humanos , Masculino , Reprodutibilidade dos Testes , Escarro/microbiologia , Fatores de Tempo , Tuberculose Pulmonar/complicações , Tuberculose Pulmonar/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA